Stay updated on Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial
Sign up to get notified when there's something new on the Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial page.

Latest updates to the Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record describes a completed Phase 3 trial of metoclopramide nasal spray versus placebo for men with diabetic gastroparesis, including its eligibility requirements, treatment plan, outcome measure, and participating locations.SummaryDifference69%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating the study record is temporarily inaccessible. The page header and footer remain, but the main content area shows an access error.SummaryDifference17%

Stay in the know with updates to Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metoclopramide Nasal Spray in Diabetic Gastroparesis Clinical Trial page.